Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Dental Phobia (EMDR-DP)

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
doerings, University Hospital Muenster
ClinicalTrials.gov Identifier:
NCT01207960
First received: June 29, 2010
Last updated: May 3, 2012
Last verified: May 2012

June 29, 2010
May 3, 2012
January 2010
September 2011   (final data collection date for primary outcome measure)
  • Dental anxiety [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
    Dental anxiety is assessed by the Dental Anxiety Scale (DAS) and the Dental Fear Survey (DFS).
  • Dental anxiety [ Time Frame: 3 months ] [ Designated as safety issue: No ]
    Dental anxiety is assessed by the Dental Anxiety Scale (DAS) and the Dental Fear Survey (DFS).
  • Dental anxiety [ Time Frame: 12 months ] [ Designated as safety issue: No ]
    Dental anxiety is assessed by the Dental Anxiety Scale (DAS) and the Dental Fear Survey (DFS).
Same as current
Complete list of historical versions of study NCT01207960 on ClinicalTrials.gov Archive Site
  • General psychopathology [ Time Frame: 4 weeks, 3 months, 12 months ] [ Designated as safety issue: No ]
    General psychopathology is assessed by the Brief Symptom Scale (BSI).
  • Anxiety and depression [ Time Frame: 4 weeks, 3 months, 12 months ] [ Designated as safety issue: No ]
    Anxiety and depression are assessed by the Hospital Anxiety and Depression Scale (HADS).
  • Behavioral test [ Time Frame: 4 weeks ] [ Designated as safety issue: No ]
    Dentral anxiety is assessed during a dental visit before and after treatment/wait-list control condition by means of a standardized behavior obeservation and interview.
  • Dental treatment [ Time Frame: 3 months, 12 months ] [ Designated as safety issue: No ]
    Does the patient tolerate dental treatment within 3 and 12 months after Eye Movement Desensitization and Reprocessing (EMDR)?
Same as current
Not Provided
Not Provided
 
Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Dental Phobia
A Randomized Wait-list Control Study of the Efficacy of Eye Movement Desensitization and Reprocessing (EMDR) in Patients With Dental Phobia

The purpose of this study is to find out whether Eye Movement Desensitization and Reprocessing (EMDR) is effective in the treatment of patients with dental phobia.

Dental phobia represents a clinical condition that affects 5-15% of the community and is characterized by severe anxiety of dental treatment which leads to avoidance of treatment and, as a consequence, severe dental as well as psychosocial problems.

Eye Movement Desensitization and Reprocessing (EMDR) has been developed for the treatment of patients with post traumatic stress disorder (PTSD). Its efficacy in PTSD patients has often been demonstrated in randomized controlled trials.

Recently it has been demonstrated that dental phobia is often induced by traumatic events during dental treatment and goes along with symptoms of PTSD in numerous patients.

A pilot study (de Jongh et al. 2002) gave hints on the efficacy of EMDR in four dental phobia patients with a history of traumatization during dental treatment.

This randomized wait-list control study aims to evaluate the efficacy of EMDR in a larger sample of dental phobia patients.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Dental Phobia
Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)
The intervention consists of three 90-minute sessions of individual psychotherapy. Sessions take place weekly according to a treatment manual.
  • Active Comparator: EMDR
    Eye Movement Desensitization and Reprocessing
    Intervention: Behavioral: Eye Movement Desensitization and Reprocessing (EMDR)
  • No Intervention: WLC
    Wait-list control group. EMDR treatment takes place after 4 weeks of no treatment which represents the wait-list comparison interval.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
24
September 2011
September 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • dental phobia according to the World Health Organization´s International Classification of Diseases, ICD-10 (F40.2)

Exclusion Criteria:

  • schizophrenic disorder
  • severe depression
  • severe dissociative disorder
  • organic brain disease
  • anorexia nervosa (body mass index, BMI < 17)
  • suicidality
  • severe cardio-vascular disease
  • ophthalmic disease
  • pregnancy and lactation
  • psychopharmacological treatment
  • substance abuse
Both
18 Years to 75 Years
No
Contact information is only displayed when the study is recruiting subjects
Germany
 
NCT01207960
2007-137-f-S
No
doerings, University Hospital Muenster
University Hospital Muenster
Not Provided
Principal Investigator: Stephan Doering, MD University of Muenster, Germany
University Hospital Muenster
May 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP